Today news
About the same in other media
Torrent Pharma says US FDA issues 'EIR' for company's manufacturing facility
Reading now: 727
Torrent Pharmaceuticals on Thursday said that the US Food and Drug Administration (US FDA) has issued an Establishment Inspection Report (“EIR”) for the company's manufacturing facility at Dahej, Gujarat.
EIR means closure of inspection.
It said that inspection has now been successfully closed by the US FDA. Earlier in March 2019, the Dahej facility was placed under Official Action Indicated (OAI) by the US FDA.
The drug regulator had conducted re-inspection of the site in May this year from 17-25-May and issued Form 483 with 2 observations, the company said in a statement.
About this in other media
Exclusive-Brazil's Petrobras plans China subsidiary in push to boost ties, CEO says investing.com /1 year ago
Market Wrap: Sensex, Nifty end flat amid weak global cues; mid, smallcaps continue their outperformance livemint.com /1 year ago
Stocks to Watch: Zomato, Sun Pharma, ONGC, LTI Mindtree, Adani group companies livemint.com /1 year ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
